Dr Margaret Chan of China was nominated today by the Executive Board of the World Health Organization for the post of Director-General. The Director-General is WHO’s chief technical and administrative officer.
Overall, the use of drugs that reduce stomach acid, such as H2 blockers and proton pump inhibitors, do not increase the risk of cancer of the esophagus or stomach, but it is informed that cancer risk is probably due to underlying conditions.
The Centre has asked the Assam government for information about the cataract operations performed last month at the Regional Institute of Opthalmology in Guwahati in which 38 patients lost their eyesight.
UNICEF is distressed by the extraordinary violence in northern Gaza. Since 1 November, we estimate that 68 Palestinians have been killed, including 14 children. The deaths during the last seven days, including the children killed in today’s shelling, add to the steady deadly toll on Palestinian children since the Intifada broke out in 2000, with 113 children killed so far this year. This is more than double the total figure for 2005.
WFP has welcomed a generous contribution of US$2 million from the Russian Federation to WFP?s emergency operation in Kenya, praising the first donation from the Russian Federation to WFP?s work in East Africa.
Younger women with ovarian cancer have better survival rates than older patients, even if they have surgery to conserve their fertility, added family history of the illness is the most important risk factor and it is influenced by hormones.
Australian senators signalled in an intial vote on Tuesday that a ban on the use of cloned human embryos for stem cell research is likely to be overturned, the purpose of the bill is to legalise therapeutic cloning.
Results of a Portuguese study suggest that, contrary to expectations, obesity is not associated with an increased risk of asthma.
In a recent Public Health Advisory, FDA summarized two new studies that practitioners should consider when making decisions about prescribing SSRIs and other antidepressant medications for pregnant women and those planning a pregnancy.
IDM Pharma (NASDAQ:IDMI) announced today that the company has submitted a Marketing Authorization Application (MAA) in eCTD format (electronic common technical document) to the European Medicines Agency (EMEA) for Mepact (mifamurtide for injection), requesting approval for its use in the treatment of patients with newly diagnosed resectable high-grade osteosarcoma following surgical resection in combination with post-operative multi-agent chemotherapy. This announcement follows the October 25, 2006 submission of a New Drug Application (NDA) for Junovan (mifamurtide for injection) to the Food and Drug Administration (FDA) in the United States.